Related Tags >> Vaccines National Institutes of Health Sequella pipeline

Tuberculosis News

Most Popular Tuberculosis Story

J&J, TB Alliance partner on TB drug

June 17, 2009 — 9:47am ET | By Maureen Martino

Tibotec, a Johnson & Johnson company, has partnered with the nonprofit Global Alliance for TB Drug Development covering Tibotec's drug TMC207. According to the World Health Organization, two... Read more...

Tuberculosis Press Releases

New TB Vaccine Candidate Enters Phase IIb Proof-of-Concept Trial in South Africa
Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609
Research identifies type of vaccine that holds promise in protecting against TB
The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
Sequella receives $2.3M NIH grant for the development of tuberculosis antibiotic drug SQ641

Latest Headlines

J&J, TB Alliance partner on TB drug
June 17, 2009
Oxford-Emergent venture gains $16M for TB vaccine trial
July 23, 2008
Global demographic trends threaten drug industry
May 14, 2008
Biotech nonprofit to make meds with donated IP
January 28, 2008

Paid Research Reports

More Research Reports >>